Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 497597, 6 pages
http://dx.doi.org/10.1155/2015/497597
Clinical Study

Phase II, Open Label, Randomized Comparative Trial of Ondansetron Alone versus the Combination of Ondansetron and Aprepitant for the Prevention of Nausea and Vomiting in Patients with Hematologic Malignancies Receiving Regimens Containing High-Dose Cytarabine

Department of Leukemia, MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 428, Houston, TX 77030, USA

Received 14 November 2014; Accepted 27 December 2014

Academic Editor: Francesco Onida

Copyright © 2015 Talha Badar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Talha Badar, Jorge Cortes, Gautam Borthakur, et al., “Phase II, Open Label, Randomized Comparative Trial of Ondansetron Alone versus the Combination of Ondansetron and Aprepitant for the Prevention of Nausea and Vomiting in Patients with Hematologic Malignancies Receiving Regimens Containing High-Dose Cytarabine,” BioMed Research International, vol. 2015, Article ID 497597, 6 pages, 2015. https://doi.org/10.1155/2015/497597.